Preparation and characterization of sunitinib-loaded microspheres for arterial embolization  

载舒尼替尼栓塞微球的制备及体外性质研究(英文)

作　　者：赵子明[1] 李佳林[1] 杨勇杰[1] 崔代超[1] 卢晓静[1] 范田园[1] 

机构地区：[1]北京大学药学院药剂学系天然药物及仿生药物国家重点实验室,北京100191

出　　处：《Journal of Chinese Pharmaceutical Sciences》2014年第8期558-564,共7页中国药学（英文版）

基　　金：State Key Projects(Grant No.2009ZX09310-001)

摘　　要：Drug-loaded microspheres have been caused much attention in embotherapy in recent years. In thlS StUdy, poiyvlnyi alcohol/acrylic acid microspheres were prepared by inverse suspension polymerization method. Sunitinih malate （SU） was used as a model drug and loaded on microspheres through ion-exchange mechanism. We investigated the characterization of blank microspheres （B-Ms） and sunitinib-loaded microspheres （SU-Ms） in vitro, including morphology, size distribution, equilibrium water content （EWC）, elasticity, drug loading and drug release. The result showed that both B-Ms and SU-Ms were spherical with smooth surface. The particle size of B-Ms and SU-Ms were both suitable for embolization. Compared with that of B-Ms, the EWC of SU-Ms was decreased and the rigidity of SU-Ms was increased. Drug loading and entrapment efficiency of microspheres were mainly affected by the concentration of sunitinib solution than by the size of microspheres. SU-Ms exhibited a sustained release in phosphate buffer solution （PBS）. Thus, the SU-Ms may have potential application for arterial embolization.近年来载药微球在栓塞治疗中引起了广泛关注。本研究采用反相悬浮聚合法制备了用于栓塞的聚乙烯醇/丙烯酸微球,首先筛分出粒径在100–1000μm范围的微球,并以舒尼替尼为模型药物,根据离子交换原理制备出载药微球;系统地评价了空白微球(B-Ms)和载药微球(SU-Ms)的理化性质:微球的形态、粒径及其分布、平衡含水量、弹性性质等,考察了微球的载药和体外释药的规律。结果显示:微球外观圆整,载药前后微球的粒径均适用于栓塞,载药后微球平衡含水量下降,刚性增加,载药前后微球的弹性均适于栓塞;微球载药量和包封率主要受药液浓度的影响,载药微球在磷酸盐缓冲液(PBS)中缓慢释药,因此,舒尼替尼载药微球具有动脉栓塞治疗的潜在应用价值。

关 键 词：MICROSPHERES EMBOLIZATION SUNITINIB Sustained release 

分 类 号：R944[医药卫生—药剂学]